Cargando…

Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d’Ivoire

For lymphatic filariasis (LF) elimination, endemic countries must document the burden of LF morbidity (LFM). Community-based screening (CBS) is used to collect morbidity data, but evidence demonstrating its reliability is limited. Recent pilots of CBS for LFM alongside mass drug administration (MDA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Hope, Konan, Daniele O., Brahima, Kouma, Koffi, Jeanne d’Arc, Kashindi, Saidi, Edmiston, Melissa, Weiland, Stefanie, Halliday, Katherine, Pullan, Rachel L., Meite, Aboulaye, Koudou, Benjamin Guibehi, Timothy, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022321/
https://www.ncbi.nlm.nih.gov/pubmed/36962795
http://dx.doi.org/10.1371/journal.pgph.0000760
_version_ 1784908705267974144
author Simpson, Hope
Konan, Daniele O.
Brahima, Kouma
Koffi, Jeanne d’Arc
Kashindi, Saidi
Edmiston, Melissa
Weiland, Stefanie
Halliday, Katherine
Pullan, Rachel L.
Meite, Aboulaye
Koudou, Benjamin Guibehi
Timothy, Joseph
author_facet Simpson, Hope
Konan, Daniele O.
Brahima, Kouma
Koffi, Jeanne d’Arc
Kashindi, Saidi
Edmiston, Melissa
Weiland, Stefanie
Halliday, Katherine
Pullan, Rachel L.
Meite, Aboulaye
Koudou, Benjamin Guibehi
Timothy, Joseph
author_sort Simpson, Hope
collection PubMed
description For lymphatic filariasis (LF) elimination, endemic countries must document the burden of LF morbidity (LFM). Community-based screening (CBS) is used to collect morbidity data, but evidence demonstrating its reliability is limited. Recent pilots of CBS for LFM alongside mass drug administration (MDA) in Côte d’Ivoire suggested low LFM prevalence (2.1–2.2 per 10,000). We estimated LFM prevalence in Bongouanou District, Côte d’Ivoire, using a comparative cross-sectional design. We compared CBS implemented independently of MDA, adapted from existing Ministry of Health protocols, to a population-based prevalence survey led by formally trained nurses. We evaluated the reliability of case identification, coverage, equity, and cost of CBS. CBS identified 87.4 cases of LFM per 10,000; the survey identified 47.5 (39.4–56.3; prevalence ratio [PR] 1.84; 95% CI 1.64–2.07). CBS identified 39.7 cases of suspect lymphoedema per 10,000; the survey confirmed 35.1 (29.2–41.5) filarial lymphoedema cases per 10,000 (PR 1.13 [0.98–1.31]). CBS identified 96.5 scrotal swellings per 10,000; the survey found 91.3 (83.2–99.8; PR 1.06 [0.93–1.21]); including 33.9 (27.7–38.8) filarial hydrocoele per 10,000 (PR of suspect to confirmed hydrocele 2.93 [2.46–3.55]). Positive predictive values for case identification through CBS were 65.0% (55.8–73.5%) for filarial lymphoedema; 93.7% (89.3–96.7%) for scrotal swellings; and 34.0% (27.3–41.2%) for filarial hydrocoele. Households of lower socioeconomic status and certain minority languages were at risk of exclusion. Direct financial costs were $0.17 per individual targeted and $69.62 per case confirmed. Our community-based approach to LFM burden estimation appears scalable and provided reliable prevalence estimates for LFM, scrotal swellings and LF-lymphoedema. The results represent a step-change improvement on CBS integrated with MDA, whilst remaining at programmatically feasible costs. Filarial hydrocoele cases were overestimated, attributable to the use of case definitions suitable for mass-screening by informal staff. Our findings are broadly applicable to countries aiming for LF elimination using CBS. The abstract is available in French in the S1 File.
format Online
Article
Text
id pubmed-10022321
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100223212023-03-17 Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d’Ivoire Simpson, Hope Konan, Daniele O. Brahima, Kouma Koffi, Jeanne d’Arc Kashindi, Saidi Edmiston, Melissa Weiland, Stefanie Halliday, Katherine Pullan, Rachel L. Meite, Aboulaye Koudou, Benjamin Guibehi Timothy, Joseph PLOS Glob Public Health Research Article For lymphatic filariasis (LF) elimination, endemic countries must document the burden of LF morbidity (LFM). Community-based screening (CBS) is used to collect morbidity data, but evidence demonstrating its reliability is limited. Recent pilots of CBS for LFM alongside mass drug administration (MDA) in Côte d’Ivoire suggested low LFM prevalence (2.1–2.2 per 10,000). We estimated LFM prevalence in Bongouanou District, Côte d’Ivoire, using a comparative cross-sectional design. We compared CBS implemented independently of MDA, adapted from existing Ministry of Health protocols, to a population-based prevalence survey led by formally trained nurses. We evaluated the reliability of case identification, coverage, equity, and cost of CBS. CBS identified 87.4 cases of LFM per 10,000; the survey identified 47.5 (39.4–56.3; prevalence ratio [PR] 1.84; 95% CI 1.64–2.07). CBS identified 39.7 cases of suspect lymphoedema per 10,000; the survey confirmed 35.1 (29.2–41.5) filarial lymphoedema cases per 10,000 (PR 1.13 [0.98–1.31]). CBS identified 96.5 scrotal swellings per 10,000; the survey found 91.3 (83.2–99.8; PR 1.06 [0.93–1.21]); including 33.9 (27.7–38.8) filarial hydrocoele per 10,000 (PR of suspect to confirmed hydrocele 2.93 [2.46–3.55]). Positive predictive values for case identification through CBS were 65.0% (55.8–73.5%) for filarial lymphoedema; 93.7% (89.3–96.7%) for scrotal swellings; and 34.0% (27.3–41.2%) for filarial hydrocoele. Households of lower socioeconomic status and certain minority languages were at risk of exclusion. Direct financial costs were $0.17 per individual targeted and $69.62 per case confirmed. Our community-based approach to LFM burden estimation appears scalable and provided reliable prevalence estimates for LFM, scrotal swellings and LF-lymphoedema. The results represent a step-change improvement on CBS integrated with MDA, whilst remaining at programmatically feasible costs. Filarial hydrocoele cases were overestimated, attributable to the use of case definitions suitable for mass-screening by informal staff. Our findings are broadly applicable to countries aiming for LF elimination using CBS. The abstract is available in French in the S1 File. Public Library of Science 2022-08-31 /pmc/articles/PMC10022321/ /pubmed/36962795 http://dx.doi.org/10.1371/journal.pgph.0000760 Text en © 2022 Simpson et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Simpson, Hope
Konan, Daniele O.
Brahima, Kouma
Koffi, Jeanne d’Arc
Kashindi, Saidi
Edmiston, Melissa
Weiland, Stefanie
Halliday, Katherine
Pullan, Rachel L.
Meite, Aboulaye
Koudou, Benjamin Guibehi
Timothy, Joseph
Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d’Ivoire
title Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d’Ivoire
title_full Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d’Ivoire
title_fullStr Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d’Ivoire
title_full_unstemmed Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d’Ivoire
title_short Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d’Ivoire
title_sort effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: a comparative cross-sectional investigation in côte d’ivoire
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022321/
https://www.ncbi.nlm.nih.gov/pubmed/36962795
http://dx.doi.org/10.1371/journal.pgph.0000760
work_keys_str_mv AT simpsonhope effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT konandanieleo effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT brahimakouma effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT koffijeannedarc effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT kashindisaidi effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT edmistonmelissa effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT weilandstefanie effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT hallidaykatherine effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT pullanrachell effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT meiteaboulaye effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT koudoubenjaminguibehi effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire
AT timothyjoseph effectivenessofcommunitybasedburdenestimationtoachieveeliminationoflymphaticfilariasisacomparativecrosssectionalinvestigationincotedivoire